BGI Genomics
Overview
BGI Genomics Co., Ltd. engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally. The company offers DNA sequencing services comprising plant/animal/microbial whole genome re-sequencing and de novo sequencing; human whole genome sequencing, long-read human whole genome resequencing, and whole exome sequencing; epigenetics whole genome bisulfite sequencing and ChIp-Seq; and metagenomics and 16S/18
Employees3580
Market Cap$14.5B
Revenue$3.8B
Listed OnShenzhen Stock Exchange
Ticker300676
CEOMr. Yujue Wang
HeadquartersShenzhen